Related references
Note: Only part of the references are listed.Trends in Cardiovascular Medicine Use in 65 Middle- and High-Income Countries
Vincent K. C. Yan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality
Hong Xu et al.
NEUROLOGY (2021)
Treatment Patterns of Patients with All-Cause Dementia in Russia
Karel Kostev et al.
JOURNAL OF ALZHEIMERS DISEASE REPORTS (2020)
Trends of antidementia drugs use in outpatients with Alzheimer's disease in six major cities of China: 2012-2017
Lingyan Yu et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2019)
Diagnosis and Management of Dementia: Review
Zoe Arvanitakis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries
Yingfen Hsia et al.
LANCET INFECTIOUS DISEASES (2019)
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Emma Nichols et al.
LANCET NEUROLOGY (2019)
France removes state funding for dementia drugs
Sebastian Walsh et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Acetylcholinesterase inhibitors and risk of stroke and death in people with dementia
Edwin C. K. Tan et al.
ALZHEIMERS & DEMENTIA (2018)
A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia
Ruth Knight et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2018)
The collapse of the Venezuelan health system
[Anonymous]
LANCET (2018)
What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink
Venexia M. Walker et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Effect of Medicare Part D on Ethnoracial Disparities in Antidementia Medication Use
Kimberly E. Lind et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2018)
A Comparison of the Prevalence of Dementia in the United States in 2000 and 2012
Kenneth M. Langa et al.
JAMA INTERNAL MEDICINE (2017)
A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer's Disease Patients
Nawal Bent-Ennakhil et al.
NEUROLOGY AND THERAPY (2017)
Trends in the Prescription and Long-Term Utilization of Antidementia Drugs Among Patients with Alzheimer's Disease in Spain: A Cohort Study Using the Registry of Dementias of Girona
Laia Calvo-Perxas et al.
DRUGS & AGING (2017)
Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015: a longitudinal retrospective cohort study
Katherine Donegan et al.
LANCET PUBLIC HEALTH (2017)
Pharmaceutical Use and Spending Trend in Medicare Beneficiaries With Dementia, From 2006 to 2012
Inmaculada Hernandez et al.
GERONTOLOGY AND GERIATRIC MEDICINE (2017)
Observational cohort study: deprivation and access to anti-dementia drugs in the UK
Claudia Cooper et al.
AGE AND AGEING (2016)
Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study
Daniela Koller et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2016)
Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer's dementia: a pooled area under the curve analysis
Alireza Atri et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
The Rising Tide of dementia in Canada: What does it mean for pharmacists and the people they care for?
Feng Chang et al.
CANADIAN PHARMACISTS JOURNAL (2015)
Antidementia Drug Treatment in People Screened Positive for Dementia in Primary Care
Diana Wucherer et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Persistence and Adherence With Dementia Pharmacotherapy: Relevance of Patient, Provider, and System Factors
Colleen J. Maxwell et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2014)
Factors Associated with Response to Acetylcholinesterase Inhibition in Dementia: A Cohort Study from a Secondary Mental Health Care Case Register in London
Gayan Perera et al.
PLOS ONE (2014)
The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimers disease
Peter Nordstrom et al.
EUROPEAN HEART JOURNAL (2013)
Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study
Carlos Martinez et al.
BMJ OPEN (2013)
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
Robert Howard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
EFNS guidelines for the diagnosis and management of Alzheimer's disease
J. Hort et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
International price comparisons of Alzheimer's drugs: a way to close the affordability gap
Guk-Hee Suh et al.
INTERNATIONAL PSYCHOGERIATRICS (2009)
Current Pharmacologic treatment of dementia: A clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2008)
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors
Raj N. Kalaria et al.
LANCET NEUROLOGY (2008)
Ageing and dementia in low and middle income countries - Using research to engage with public and policy makers
Martin Prince et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2008)
The protocols for the 10/66 dementia research group population-based research programme
Martin Prince et al.
BMC PUBLIC HEALTH (2007)
Share Paper
